The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage
Yi-Che Lee,1–3 Chih-Ting Huang,4 Fong-Yu Cheng,5 Shih-Yuan Hung,3,6 Tsun-Mei Lin,7 Yen-Chang Tsai,4 Chih-I Chen,8 Hao-Kuang Wang,9 Chi-Wei Lin,10 Hung-Hsiang Liou,11 Min-Yu Chang,3 Hsi-Hao Wang,3 Yuan-Yow Chiou4,12 1Division of Nephrology, Department of Internal Medicine, E-DA Dachang Hosp...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2019
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2d35ffeeb3f5415d856808a915c925e0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2d35ffeeb3f5415d856808a915c925e0 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2d35ffeeb3f5415d856808a915c925e02021-12-02T09:39:08ZThe Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage1178-2013https://doaj.org/article/2d35ffeeb3f5415d856808a915c925e02019-12-01T00:00:00Zhttps://www.dovepress.com/the-clinical-implication-of-vitamin-d-nanomedicine-for-peritoneal-dial-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yi-Che Lee,1–3 Chih-Ting Huang,4 Fong-Yu Cheng,5 Shih-Yuan Hung,3,6 Tsun-Mei Lin,7 Yen-Chang Tsai,4 Chih-I Chen,8 Hao-Kuang Wang,9 Chi-Wei Lin,10 Hung-Hsiang Liou,11 Min-Yu Chang,3 Hsi-Hao Wang,3 Yuan-Yow Chiou4,12 1Division of Nephrology, Department of Internal Medicine, E-DA Dachang Hospital/ I-Shou University, Kaohsiung, Taiwan; 2School of Medicine, College of Medicine; 3Division of Nephrology, Department of Internal Medicine, E-DA Hospital/ I-Shou University, Kaohsiung, Taiwan; 4Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 5Department of Chemistry, Chinese Culture University, Taipei, Taiwan; 6School of Medicine for International Students; 7Department of Laboratory Medicine; 8Division of Colorectal Surgery, Department of Surgery; 9Department of Neurosurgery; 10Department of Medical Education, E-DA Hospital/ I-Shou University, Kaohsiung, Taiwan; 11Division of Nephrology, Department of Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan; 12Department of Pediatrics, National Cheng Kung University Hospital, Tainan, TaiwanCorrespondence: Yi-Che LeeDivision of Nephrology, Department of Internal Medicine, E-DA Hospital/I-Shou University, No.1, Yida Road, Jiaosu Village, Yanchao District, Kaohsiung City 82445, Taiwan, ROCTel +886-7-6150011 ext. 5121Email pipijer@gmail.com Yuan-Yow ChiouInstitute of Clinical Medicine, Department of Pediatrics, National Cheng Kung University Hospital, Medical College, No. 138, Sheng-Li Road, Tainan City 701, Taiwan, ROCTel +886-6-2353535 ext. 4184Fax +886-6-2753083Email yuanyow@mail.ncku.edu.twPurpose: Vitamin D is a novel potential therapeutic agent for peritoneal dialysis (PD)-related peritoneal fibrosis, but it can induce hypercalcemia and vascular calcification, which limits its applicability. In this study, we create nanotechnology-based drug delivery systems to investigate its therapeutics and side effects.Materials and methods: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N- [amino-(polyethylene glycol)2000] (DSPE-PEG) and L-α-phosphatidylcholine (PC), which packages with 1α,25(OH)2D3, were used to construct vitamin D nanoliposomes. To confirm the function and safety of vitamin D nanoliposomes, peritoneal mesothelial cells were treated with TGF-β1 and the reverse was attempted using vitamin D nanoliposomes. Antibodies (Ab) against the peritoneum-glycoprotein M6A (GPM6A) Ab were conjugated with vitamin D nanoliposomes. These particles were implanted into mice by intraperitoneal injection and the animals were monitored for the distribution and side effects induced by vitamin D.Results: Vitamin D nanoliposomes were taken up by the mesothelial cells over time without cell toxicity and it also provided the same therapeutic effect in vitro. In vivo study, fluorescent imaging showed vitamin D nanoliposomes allow specific peritoneum target effect and also ameliorate vitamin D side effect.Conclusion: Nanoliposomes vitamin D delivery systems for the prevention of PD-related peritoneal damage may be a potential clinical strategy in the future.Keywords: peritoneal dialysis, nanoliposome, vitamin D, fibrosisLee YCHuang CTCheng FYHung SYLin TMTsai YCChen CIWang HKLin CWLiou HHChang MYWang HHChiou YYDove Medical Pressarticleperitoneal dialysisnanoliposomevitamin dfibrosisMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 9665-9675 (2019) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
peritoneal dialysis nanoliposome vitamin d fibrosis Medicine (General) R5-920 |
| spellingShingle |
peritoneal dialysis nanoliposome vitamin d fibrosis Medicine (General) R5-920 Lee YC Huang CT Cheng FY Hung SY Lin TM Tsai YC Chen CI Wang HK Lin CW Liou HH Chang MY Wang HH Chiou YY The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| description |
Yi-Che Lee,1–3 Chih-Ting Huang,4 Fong-Yu Cheng,5 Shih-Yuan Hung,3,6 Tsun-Mei Lin,7 Yen-Chang Tsai,4 Chih-I Chen,8 Hao-Kuang Wang,9 Chi-Wei Lin,10 Hung-Hsiang Liou,11 Min-Yu Chang,3 Hsi-Hao Wang,3 Yuan-Yow Chiou4,12 1Division of Nephrology, Department of Internal Medicine, E-DA Dachang Hospital/ I-Shou University, Kaohsiung, Taiwan; 2School of Medicine, College of Medicine; 3Division of Nephrology, Department of Internal Medicine, E-DA Hospital/ I-Shou University, Kaohsiung, Taiwan; 4Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 5Department of Chemistry, Chinese Culture University, Taipei, Taiwan; 6School of Medicine for International Students; 7Department of Laboratory Medicine; 8Division of Colorectal Surgery, Department of Surgery; 9Department of Neurosurgery; 10Department of Medical Education, E-DA Hospital/ I-Shou University, Kaohsiung, Taiwan; 11Division of Nephrology, Department of Medicine, Hsin-Jen Hospital, New Taipei City, Taiwan; 12Department of Pediatrics, National Cheng Kung University Hospital, Tainan, TaiwanCorrespondence: Yi-Che LeeDivision of Nephrology, Department of Internal Medicine, E-DA Hospital/I-Shou University, No.1, Yida Road, Jiaosu Village, Yanchao District, Kaohsiung City 82445, Taiwan, ROCTel +886-7-6150011 ext. 5121Email pipijer@gmail.com
Yuan-Yow ChiouInstitute of Clinical Medicine, Department of Pediatrics, National Cheng Kung University Hospital, Medical College, No. 138, Sheng-Li Road, Tainan City 701, Taiwan, ROCTel +886-6-2353535 ext. 4184Fax +886-6-2753083Email yuanyow@mail.ncku.edu.twPurpose: Vitamin D is a novel potential therapeutic agent for peritoneal dialysis (PD)-related peritoneal fibrosis, but it can induce hypercalcemia and vascular calcification, which limits its applicability. In this study, we create nanotechnology-based drug delivery systems to investigate its therapeutics and side effects.Materials and methods: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N- [amino-(polyethylene glycol)2000] (DSPE-PEG) and L-α-phosphatidylcholine (PC), which packages with 1α,25(OH)2D3, were used to construct vitamin D nanoliposomes. To confirm the function and safety of vitamin D nanoliposomes, peritoneal mesothelial cells were treated with TGF-β1 and the reverse was attempted using vitamin D nanoliposomes. Antibodies (Ab) against the peritoneum-glycoprotein M6A (GPM6A) Ab were conjugated with vitamin D nanoliposomes. These particles were implanted into mice by intraperitoneal injection and the animals were monitored for the distribution and side effects induced by vitamin D.Results: Vitamin D nanoliposomes were taken up by the mesothelial cells over time without cell toxicity and it also provided the same therapeutic effect in vitro. In vivo study, fluorescent imaging showed vitamin D nanoliposomes allow specific peritoneum target effect and also ameliorate vitamin D side effect.Conclusion: Nanoliposomes vitamin D delivery systems for the prevention of PD-related peritoneal damage may be a potential clinical strategy in the future.Keywords: peritoneal dialysis, nanoliposome, vitamin D, fibrosis |
| format |
article |
| author |
Lee YC Huang CT Cheng FY Hung SY Lin TM Tsai YC Chen CI Wang HK Lin CW Liou HH Chang MY Wang HH Chiou YY |
| author_facet |
Lee YC Huang CT Cheng FY Hung SY Lin TM Tsai YC Chen CI Wang HK Lin CW Liou HH Chang MY Wang HH Chiou YY |
| author_sort |
Lee YC |
| title |
The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| title_short |
The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| title_full |
The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| title_fullStr |
The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| title_full_unstemmed |
The Clinical Implication of Vitamin D Nanomedicine for Peritoneal Dialysis-Related Peritoneal Damage |
| title_sort |
clinical implication of vitamin d nanomedicine for peritoneal dialysis-related peritoneal damage |
| publisher |
Dove Medical Press |
| publishDate |
2019 |
| url |
https://doaj.org/article/2d35ffeeb3f5415d856808a915c925e0 |
| work_keys_str_mv |
AT leeyc theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT huangct theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT chengfy theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT hungsy theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT lintm theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT tsaiyc theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT chenci theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT wanghk theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT lincw theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT liouhh theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT changmy theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT wanghh theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT chiouyy theclinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT leeyc clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT huangct clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT chengfy clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT hungsy clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT lintm clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT tsaiyc clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT chenci clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT wanghk clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT lincw clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT liouhh clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT changmy clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT wanghh clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage AT chiouyy clinicalimplicationofvitamindnanomedicineforperitonealdialysisrelatedperitonealdamage |
| _version_ |
1718398056458616832 |